AICAR (100mg)
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is an AMP analogue that activates AMPK and is studied as an "exercise mimetic" at the cellular level. Research-use literature describes subcutaneous administration of 1–3 mg once daily with gradual titration.
Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer
Research monograph
See the full AICAR encyclopedia page with mechanism, evidence tier, related variants and research context.
How It Works
AICAR directly activates AMP-activated protein kinase (AMPK), increasing fatty acid oxidation, glucose uptake into muscles, mitochondrial biogenesis, and angiogenesis — processes normally activated by aerobic exercise.
Quick Start
- Reconstitution: Add 5.0 mL bacteriostatic water → 20 mg/mL concentration.
- Literature-reported range: 1–3 mg once daily (gradual titration).
- Easy measurement: At 20 mg/mL, 1 unit = 0.01 mL = 200 mcg on a U-100 syringe.
- Storage: Lyophilized: −20 °C; reconstituted: 2–8 °C, use within 28 days.
Literature-reported ranges (5.0 mL = 20 mg/mL)
Route: Subcutaneously | Frequency: Once daily
| Week | Dose | Units (per injection) |
|---|---|---|
| Weeks 1–2 | 1 mg | 5 Units (0.05 mL) |
| Weeks 3–4 | 2 mg | 10 Units (0.10 mL) |
| Weeks 5–8 | 3 mg | 15 Units (0.15 mL) |
Research-use literature reports subcutaneous administration once daily, increasing by 1 mg every 2 weeks. Sources vary considerably and there is no validated human dosing.
Related compounds
Reconstitution Steps
- Draw 5.0 mL of bacteriostatic water.
- Inject slowly down the vial wall; avoid foaming.
- Swirl gently until fully dissolved — do not shake.
- Note the reconstitution date and refrigerate at 2–8 °C.
Protocol Overview
- Literature-reported scope: AMPK activation, glucose and fatty-acid metabolism (mostly preclinical data).
- Literature-described schedule: 1 → 2 → 3 mg daily over 8 weeks.
Dosing Protocol
- Weeks 1–2: 1 mg daily.
- Weeks 3–4: 2 mg daily.
- Weeks 5–8: 3 mg daily.
- Literature-described break: 4 weeks after the cycle.
- Break between cycles: After the 8-week cycle, the literature describes a 4-week break.
Washout & Cycle Restart
When can I restart?
After the 8-week cycle, the literature describes a 4-week break.
Minimum wait period: 4 weeks
Storage Instructions
- Lyophilized: −20 °C in dry, dark conditions.
- Reconstituted: 2–8 °C; use within 28 days.
- Avoid freeze-thaw cycles.
Important Notes
- WADA-banned substance.
- For research use only.
- May affect blood glucose.
Potential Benefits & Side Effects
Potential Benefits:
- AMPK activation (exercise mimetic).
- Increased fatty acid oxidation.
- Mitochondrial biogenesis.
Potential Side Effects:
- Hypoglycemia (rare).
- Gastrointestinal discomfort.
⚠️ Serious Warnings & Long-Term Risks
The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.
Bradycardia & hypotension
AICAR (acadesine) caused bradycardia and hypotension in IV clinical trials. Data for subcutaneous research use is limited.
📄 J Am Coll Cardiol 1996Uric acid increase & gout risk
Metabolized to AMP → IMP → uric acid. Chronic use may increase serum uric acid.
📄 Am J Physiol 1998References
- AICAR Activates AMPK in Skeletal Muscle — Cell (2008) — AICAR AMPK activation in muscle
View Source - AICAR as Exercise Mimetic in Mice — PNAS (2008) — AICAR exercise mimetic in mice
View Source
External Sources & Regulatory Status
Regulatory Approvals
Cardiac surgery / AMPK
Phase II (cardioprotection)
Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.
Continue Your Research
Explore tools and guides related to this protocol.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →